Literature DB >> 30859379

Prevention Strategies for Recurrent Community-Associated Staphylococcus aureus Skin and Soft Tissue Infections.

J Chase McNeil1, Stephanie A Fritz2.   

Abstract

PURPOSE OF REVIEW: Staphylococcus aureus skin and soft tissue infections (SSTI) are a major source of morbidity. More than half of patients experiencing SSTI will have at least one recurrent infection. These infections frequently cluster in households. Given the burden these infections pose to patients and healthcare, prevention strategies are of major clinical importance and represent an active area of research. Bacterial colonization is frequently an early and critical step in the pathogenesis of infection. As such, strategies to prevent reinfection have aimed to decrease staphylococcal colonization of the skin and mucus membranes, a process referred to as decolonization. RECENT
FINDINGS: Treatment of acute SSTI with incision and drainage and systemic antibiotics is the mainstay of therapy for healing of the acute infection. Systemic antibiotics also provide benefit through reduced incidence of recurrent SSTI. Education for patients and families regarding optimization of personal and household hygiene measures, and avoidance of sharing personal hygiene items, is an essential component in prevention efforts. For patients experiencing recurrent SSTI, or in households in which multiple members have experienced SSTI, decolonization should be recommended for all household members. A recommended decolonization regimen includes application of intranasal mupirocin and antiseptic body washes with chlorhexidine or dilute bleach water baths. For patients who continue to experience recurrent SSTI, periodic decolonization should be considered. Personal decolonization with topical antimicrobials and antiseptics reduces the incidence of recurrent S. aureus SSTI. Future avenues for investigation include strategies for household environmental decontamination as well as manipulation of the host microbiota.

Entities:  

Keywords:  Decolonization; Methicillin-resistant Staphylococcus aureus; Prevention; Skin and soft tissue infection; Staphylococcus aureus

Year:  2019        PMID: 30859379     DOI: 10.1007/s11908-019-0670-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  123 in total

1.  Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.

Authors:  F L'Hériteau; J C Lucet; A Scanvic; E Bouvet
Journal:  JAMA       Date:  1999-09-15       Impact factor: 56.272

2.  Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.

Authors:  Farrin A Manian
Journal:  Clin Infect Dis       Date:  2003-01-06       Impact factor: 9.079

3.  Can bacterial interference prevent infection?

Authors:  G Reid; J Howard; B S Gan
Journal:  Trends Microbiol       Date:  2001-09       Impact factor: 17.079

4.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Three-year surveillance of community-acquired Staphylococcus aureus infections in children.

Authors:  Sheldon L Kaplan; Kristina G Hulten; Blanca E Gonzalez; Wendy A Hammerman; Linda Lamberth; James Versalovic; Edward O Mason
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

6.  Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp.

Authors:  Y Uehara; H Nakama; K Agematsu; M Uchida; Y Kawakami; A S Abdul Fattah; N Maruchi
Journal:  J Hosp Infect       Date:  2000-02       Impact factor: 3.926

7.  Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers.

Authors:  Michael W Ellis; Duane R Hospenthal; David P Dooley; Paula J Gray; Clinton K Murray
Journal:  Clin Infect Dis       Date:  2004-09-02       Impact factor: 9.079

8.  Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection.

Authors:  Kepler A Davis; Justin J Stewart; Helen K Crouch; Christopher E Florez; Duane R Hospenthal
Journal:  Clin Infect Dis       Date:  2004-08-27       Impact factor: 9.079

Review 9.  Microbial colonization and atopic dermatitis.

Authors:  Antonie Roll; Antonio Cozzio; Barbra Fischer; Peter Schmid-Grendelmeier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2004-10

10.  Human-to-dog transmission of methicillin-resistant Staphylococcus aureus.

Authors:  Engeline van Duijkeren; Maurice J H M Wolfhagen; Adrienne T A Box; Max E O C Heck; Wim J B Wannet; Ad C Fluit
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more
  3 in total

Review 1.  Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.

Authors:  Gustavo Henrique Rodrigues Vale de Macedo; Gabrielle Damasceno Evangelista Costa; Elane Rodrigues Oliveira; Glauciane Viera Damasceno; Juliana Silva Pereira Mendonça; Lucas Dos Santos Silva; Vitor Lopes Chagas; José Manuel Noguera Bazán; Amanda Silva Dos Santos Aliança; Rita de Cássia Mendonça de Miranda; Adrielle Zagmignan; Andrea de Souza Monteiro; Luís Cláudio Nascimento da Silva
Journal:  Pathogens       Date:  2021-02-02

2.  Antimicrobial and Antivirulence Action of Eugenia brejoensis Essential Oil in vitro and in vivo Invertebrate Models.

Authors:  Clovis Macêdo Bezerra Filho; Luís Cláudio Nascimento da Silva; Márcia Vanusa da Silva; Anders Løbner-Olesen; Carsten Struve; Karen Angeliki Krogfelt; Maria Tereza Dos Santos Correia; Maria Luiza Vilela Oliva
Journal:  Front Microbiol       Date:  2020-03-19       Impact factor: 5.640

Review 3.  The infectious complications of atopic dermatitis.

Authors:  Vivian Wang; Juri Boguniewicz; Mark Boguniewicz; Peck Y Ong
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-07       Impact factor: 6.347

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.